Slingshot members are tracking this event:
Celgene (CELG) Announces Phase 1b Top-Line Data From CD-001 Evaluating GED-0301 in Patients with Active Crohn's Disease
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Oct 16, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Endoscopy Trial, Cd-001, Ged-0301, Crohn's Disease